5 directors got 3M in stock options at a strike price of 0.0617 on Jan 3, 2014 (expires in 10 years but exercisable immediately) and they bought 1.3M ordinary shares on Dec 31, 2013 as well. See SEC Form 4s for more details. The fact that they got only 3M options instead of 30M or 100M means that the internal expectation is for a significant increase in valuation for a paltry 3M options (or 0.1% of the OS) to make a difference to these officers. Conjecture at this point but a decent one if I might say :).
But LPC needs to be fired, a new non-dilutive financing deal in place, great Phase 1 topline results published and Phase 2 started before the RS and uplisting can happen. If all this happens this year, I can easily see a valuation of $1B or a 6 bagger from here by Christmas.
Hey, Phase II clinical trials already showing strong signs of efficacy, the odds of favorable Phase III results are higher. Potential partnership opportunities could further catalyze our ACTC stock, to new HIGHS. Today should be the turn around day considering the insiders are finally buying AND this should be a very good Sign since they know the confidential inside information which is NOT known to the PUBLIC.